StockData
CME Group Inc. logo

CME Group Inc. (CME) stock

CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 10/3018% above fair value
$311.56−7.81 (-2.45%)

Close on Nov 17, 2026Market cap $111.52BP/E 25.6Yield 1.60%

CME operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

CME's operating cash flow for the twelve months ending Sep 30, 2026 was $4.43B, up 6.4% year over year. For fiscal 2025 it was $4.28B, up 15.9% from the year before. Over ten years it grew 10.8% a year on average. The highest annual figure on record is $4.28B in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.28B+15.9%
FY2024Dec 31, 2024$3.69B+6.9%
FY2023Dec 31, 2023$3.45B+13.0%
FY2022Dec 31, 2022$3.06B+27.2%
FY2021Dec 31, 2021$2.40B-11.5%
FY2020Dec 31, 2020$2.72B+1.6%
FY2019Dec 31, 2019$2.67B+9.5%
FY2018Dec 31, 2018$2.44B+39.4%
FY2017Dec 31, 2017$1.75B+1.1%
FY2016Dec 31, 2016$1.73B+13.0%
FY2015Dec 31, 2015$1.53B+18.7%
FY2014Dec 31, 2014$1.29B+0.9%
FY2013Dec 31, 2013$1.28B+5.0%
FY2012Dec 31, 2012$1.22B-9.4%
FY2011Dec 31, 2011$1.35B-1.0%
FY2010Dec 31, 2010$1.36B+25.5%
FY2009Dec 31, 2009$1.08B-9.5%
FY2008Dec 31, 2008$1.20B+47.0%
FY2007Dec 31, 2007$814.40M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.09B+12.2%
Q2 FY2026Jun 30, 2026$947.10M-10.5%
Q1 FY2026Mar 31, 2026$1.26B+12.8%
Q4 FY2025Dec 31, 2025$1.13B+11.4%
Q3 FY2025Sep 30, 2025$968.10M-3.5%
Q2 FY2025Jun 30, 2025$1.06B+36.2%
Q1 FY2025Mar 31, 2025$1.12B+25.1%
Q4 FY2024Dec 31, 2024$1.02B-2.5%
Q3 FY2024Sep 30, 2024$1.00B+17.1%
Q2 FY2024Jun 30, 2024$776.90M+19.4%
Q1 FY2024Mar 31, 2024$892.70M-1.1%
Q4 FY2023Dec 31, 2023$1.04B+6.4%
Q3 FY2023Sep 30, 2023$856.70M+30.2%
Q2 FY2023Jun 30, 2023$650.40M+5.3%
Q1 FY2023Mar 31, 2023$902.40M+12.9%
Q4 FY2022Dec 31, 2022$981.50M+46.9%
Q3 FY2022Sep 30, 2022$657.80M+4.1%
Q2 FY2022Jun 30, 2022$617.60M+23.6%
Q1 FY2022Mar 31, 2022$799.10M+32.6%
Q4 FY2021Dec 31, 2021$668.30M+1.2%
Q3 FY2021Sep 30, 2021$631.60M+102.8%
Q2 FY2021Jun 30, 2021$499.80M-49.4%
Q1 FY2021Mar 31, 2021$602.70M-20.4%
Q4 FY2020Dec 31, 2020$660.30M-8.3%
Q3 FY2020Sep 30, 2020$311.40M-61.6%
Q2 FY2020Jun 30, 2020$986.80M+108.3%
Q1 FY2020Mar 31, 2020$757.10M+13.1%
Q4 FY2019Dec 31, 2019$719.70M+41.0%
Q3 FY2019Sep 30, 2019$810.20M+39.1%
Q2 FY2019Jun 30, 2019$473.70M-9.4%
Q1 FY2019Mar 31, 2019$669.20M-18.9%
Q4 FY2018Dec 31, 2018$510.40M+10.9%
Q3 FY2018Sep 30, 2018$582.60M+14.8%
Q2 FY2018Jun 30, 2018$522.80M+98.0%
Q1 FY2018Mar 31, 2018$825.00M+58.8%
Q4 FY2017Dec 31, 2017$460.40M-7.8%
Q3 FY2017Sep 30, 2017$507.30M–
Q2 FY2017Jun 30, 2017$264.00M–
Q1 FY2017Mar 31, 2017$519.40M–
Q4 FY2016Dec 31, 2016$499.60M–

More CME figures

See a number that looks wrong?